Cystic Fibrosis Transmembrane Conductance Regulator Potentiator [EPC]

Known as: CFTR Potentiator, Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Potentiator, Cystic Fibrosis Transmembrane Conductance Regulator Potentiator 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
OBJECTIVE To investigate the effect of treatment with ivacaftor on insulin secretion in patients with cystic fibrosis (CF) (ΔF508… (More)
  • figure 1
Is this relevant?
2016
2016
Cystic fibrosis (CF) is a debilitating disease caused by mutations in the cystic fibrosis transmembrane conductance regulator… (More)
Is this relevant?
2014
2014
Among the arsenal of nano-materials, carbon nanotubes (CNTs) are becoming more prominent due to favorable attributes including… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
2014
2014
Quinolinone-3-carboxamide 1, a novel CFTR potentiator, was discovered using high-throughput screening in NIH-3T3 cells expressing… (More)
  • figure 1
  • table 1
  • figure 2
  • table 4
  • table 3
Is this relevant?
Review
2013
Review
2013
Cystic fibrosis (CF), a severe genetic disease, is caused by mutations that alter the structure and function of CFTR, a plasma… (More)
Is this relevant?
Highly Cited
2009
Highly Cited
2009
Cystic fibrosis (CF) is a fatal genetic disease caused by mutations in the gene encoding the CF transmembrane conductance… (More)
Is this relevant?